GlassScriptPhysician profile
Anil Mattoo
NPI 1356339139
$4,719.72
in general payments reported to CMS, 2019-2025
30 companies · $771 in 2025
The $771 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $766 · 2021: $938 · 2022: $688 · 2023: $898 · 2024: $104 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,772.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,079.42 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $837.74 | 2019-2025 | Breztri, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $500.07 | 2019-2023 | Ofev |
| Genzyme Corporation | $389.10 | 2021-2025 | |
| Grifols USA, LLC | $329.84 | 2019-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $171.29 | 2019-2024 | |
| Inspire Medical Systems, INC. | $150.31 | 2025 | Inspire |
| Ethicon INC. | $123.65 | 2022 | |
| Electromed, INC. | $119.86 | 2021-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $115.29 | 2020-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $107.60 | 2019-2023 | Keytruda |
| Mylan Specialty L.P. | $93.68 | 2021-2023 | Yupelri |
| Axsome Therapeutics, INC. | $89.69 | 2023 | Sunosi |
| Sanofi-Aventis U.S. LLC | $81.87 | 2021-2022 | |
| Lilly USA, LLC | $61.75 | 2025 | Zepbound |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $58.70 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $41.97 | 2019-2021 | |
| Philips North America LLC | $40.22 | 2023-2025 | Vest Therapy Und |
| Baxter Healthcare | $37.62 | 2022 | |
| Amgen INC. | $35.88 | 2022-2025 | Tezspire |
| Pfizer INC. | $35.37 | 2019-2025 | |
| Harmony Biosciences LLC | $34.68 | 2022 | |
| Shionogi INC | $29.65 | 2022 | |
| Mallinckrodt Hospital Products INC. | $29.03 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.19 | 2022 | |
| Inogen, INC. | $25.30 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Insmed, INC. | $19.33 | 2024 | Arikayce |
| Circassia INC. | $18.42 | 2020 | |
| Vapotherm INC | $17.88 | 2021 | |
| Ani Pharmaceuticals, INC. | $17.32 | 2023 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Mattoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.